SHANTELLE BREEZE: Open Payments
NPI 1124612452 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 14 payments from 9 companies in 2025. Trend: 2023 $129 · 2024 $245 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Aurinia Pharma U.S., Inc. | 2 | $32 |
| Vifor Pharma, Inc. | 1 | $29 |
| Vantive US Healthcare LLC | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
| Fresenius USA Marketing, Inc. | 1 | $21 |
Products named: TAVNEOS, Kerendia, Wegovy, FARXIGA, LUPKYNIS, Veltassa, Renal - Chronic, TARPEYO.
Industry payments across NC — which companies pay providers there.
